Apogee Therapeutics Inc.
(APGE)
undefined
undefined%
At close: undefined
45.00
1.65%
After-hours Dec 13, 2024, 04:41 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 |
Net Income | -83.98M | -39.78M |
Depreciation & Amortization | - | - |
Stock-Based Compensation | 6.10M | 2.14M |
Other Working Capital | 4.49M | 9.40M |
Other Non-Cash Items | -2.98M | 11.40M |
Deferred Income Tax | - | - |
Change in Working Capital | 6.11M | 9.81M |
Operating Cash Flow | -74.76M | -16.43M |
Capital Expenditures | -167.00K | - |
Acquisitions | - | - |
Purchase of Investments | -303.74M | - |
Sales Maturities Of Investments | 30.00M | - |
Other Investing Acitivies | - | - |
Investing Cash Flow | -273.91M | - |
Debt Repayment | - | - |
Common Stock Repurchased | - | - |
Dividend Paid | - | - |
Other Financial Acitivies | - | 168.50M |
Financial Cash Flow | 315.39M | 183.62K |
Net Cash Flow | -33.28M | -16.24M |
Free Cash Flow | -74.93M | -16.43M |